From 20 - 25 February, the Conference on Retroviruses and Opportunistic Infections (CROI) and CROI-affiliated International HIV Drug Resistance Workshop (RW) will take place in Boston, USA. AIGHD is sending three PhD students from the PASER-MARCH network to these conferences: Ragna Boerma, Cissy Kityo and...
From 20 - 25 February, the Conference on Retroviruses and Opportunistic Infections (CROI) and CROI-affiliated International HIV Drug Resistance Workshop (RW) will take place in Boston, USA. AIGHD is sending three PhD students from the PASER-MARCH network to these conferences: Ragna Boerma, Cissy Kityo and...
On Tuesday January 26, KIT hosted and co-organized the event “From Innovation to Impact”, in close cooperation with KNCV Tuberculosis Foundation and the Bill & Melinda Gates Foundation. Frank Cobelens represented AIGHD in the Panel debate with his introduction about vision and leadership in Global...
De resistentie van hiv tegen een van de meest gebruikte aidsremmers, tenofovir, neemt toe. Dat blijkt uit een meta-analyse gepubliceerd in The Lancet Infectious Diseases. Eerder deze week noemde eerste auteur dr. Ravi Gupta de resultaten tegenover de BBC ‘zeer zorgwekkend’. De Nederlandse internist-infectioloog in opleiding...
Potent tenofovir-containing antiretroviral regimens are increasingly used to treat and prevent HIV. Few data exist on the frequency of and risk factors for acquired drug resistance in regions hardest hit by the HIV pandemic. This collaborative study combined data from adult treatment cohorts and clinical...
It is our pleasure to announce the 10th International Workshop on HIV Treatment, Pathogenesis, and Prevention Research in Resource Limited Settings (INTEREST), on 3-6 May 2016 in the Hilton Yaoundé Hotel in Yaoundé, Cameroon. An exciting scientific program is being set up by the Organizing and...